Cargando…
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP(®) DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults
Background: Several techniques are under investigation to improve the immunogenicity of HIV-1 DNA vaccine candidates. DNA vaccines are advantageous due to their ease of design, expression of multiple antigens, and safety. Methods: The HVTN 098 trial assessed the PENNVAX(®)-GP DNA vaccine (encoding H...
Autores principales: | Edupuganti, Srilatha, C. De Rosa, Stephen, Elizaga, Marnie, Lu, Yiwen, Han, Xue, Huang, Yunda, Swann, Edith, Polakowski, Laura, A. Kalams, Spyros, Keefer, Michael, Maenza, Janine, C. Wise, Megan, Yan, Jian, Morrow, Matthew P., Khan, Amir S., Boyer, Jean D., Humeau, Laurent, White, Scott, Sardesai, Niranjan Y., Bagarazzi, Mark L., Gilbert, Peter B., Kublin, James G., Corey, Lawrence, Weiner, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762306/ https://www.ncbi.nlm.nih.gov/pubmed/33297341 http://dx.doi.org/10.3390/vaccines8040741 |
Ejemplares similares
-
Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
por: Tebas, P, et al.
Publicado: (2012) -
A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin
por: McCoy, Jay R, et al.
Publicado: (2014) -
Optimising CN54gp140 plasmid delivery by comparing intramuscular and intradermal vaccination combinations with and without electroporation
por: Mann, JF, et al.
Publicado: (2012) -
Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
por: Johansson, Daniel X., et al.
Publicado: (2012) -
Improving the Repeatability and Efficacy of Intradermal Electroporated Self-Replicating mRNA
por: Huysmans, Hanne, et al.
Publicado: (2019)